ANDREW BREMER — Lobbyist Profile | Poliscope

ANDREW BREMER

Filings

Clients

Firms

Years active

2025–2025

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH	3	2025

Lobbying firms

Firm	Filings	Years
INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH	3	2025

Bills explicitly cited in this lobbyist’s assigned issues (3)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 1082

Shandra Eisenga Human Cell and Tissue Product Safety Act

Client: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text

HR 1082, Shandra Eisenga Human Cell and Tissue Product Safety Act HR 5304, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

H.R. 1082

Shandra Eisenga Human Cell and Tissue Product Safety Act

Client: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH · Firm: INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open original LDA filing ↗

Cited source text

Original LDA source filings (3)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH via INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

2025 · fourth_quarter · Q4

Firm income: —Client expense: $30,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

SCI

Science/Technology

FY26 Labor-HHS appropriations, research with human fetal tissue

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH via INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

2025 · third_quarter · Q3

Firm income: —Client expense: $30,000

Source: Senate LDA